SUCAMPO PHARMACEUTICALS, INC. Retained Earnings
SUCAMPO PHARMACEUTICALS, INC. had Retained Earnings of -$141.37 million as of 2017-09-30, per its 10-Q filed 2017-11-01.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2017-11-01
- 2017-09-30: Retained Earnings (Accumulated Deficit) -$141.37M.
- 2017-06-30: Retained Earnings (Accumulated Deficit) -$151.74M.
- 2017-03-31: Retained Earnings (Accumulated Deficit) $41.68M.
- 2016-12-31: Retained Earnings (Accumulated Deficit) $38.13M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2017-09-30 | -$141.37M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | -$151.74M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $41.68M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $38.13M 10-Q · filed 2017-11-01 | |
| 2016-09-30 | $22.84M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $14.75M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $15.58M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $19.64M 10-K · filed 2017-03-08 | |
| 2015-09-30 | $9.49M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $2.25M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | -$7.32M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | -$13.73M 10-K/A · filed 2016-03-16 | |
| 2014-09-30 | -$23.01M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | -$24.49M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | -$26.06M 10-K · filed 2015-03-09 | -$27.01M 10-Q · filed 2014-05-09 |
| 2013-12-31 | -$26.86M 10-K · filed 2015-03-09 | -$27.68M 10-K · filed 2014-03-12 |
| 2013-09-30 | -$29.18M 10-Q · filed 2014-11-07 | -$29.83M 10-Q · filed 2013-11-08 |
| 2013-06-30 | -$31.13M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | -$36.95M 10-Q · filed 2014-11-07 | -$37.24M 10-Q · filed 2013-05-10 |
| 2012-12-31 | -$33.88M 10-Q · filed 2014-11-07 | -$34.10M 10-K · filed 2013-03-18 |
| 2012-09-30 | -$47.63M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | -$41.68M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | -$40.86M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | -$38.94M 10-K · filed 2013-03-18 | |
| 2011-09-30 | -$41.64M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | -$37.56M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | -$21.63M 10-K · filed 2012-03-15 |